EP2236159A3 - Modified release dimebolin compositions - Google Patents

Modified release dimebolin compositions Download PDF

Info

Publication number
EP2236159A3
EP2236159A3 EP10158233A EP10158233A EP2236159A3 EP 2236159 A3 EP2236159 A3 EP 2236159A3 EP 10158233 A EP10158233 A EP 10158233A EP 10158233 A EP10158233 A EP 10158233A EP 2236159 A3 EP2236159 A3 EP 2236159A3
Authority
EP
European Patent Office
Prior art keywords
dimebolin
modified release
compositions
salt
hcl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
EP10158233A
Other languages
German (de)
French (fr)
Other versions
EP2236159A2 (en
Inventor
Ahmet Toksöz
Ümit Cifter
Ali Turkyilmaz
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sanovel Ilac Sanayi ve Ticaret AS
Original Assignee
Sanovel Ilac Sanayi ve Ticaret AS
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sanovel Ilac Sanayi ve Ticaret AS filed Critical Sanovel Ilac Sanayi ve Ticaret AS
Publication of EP2236159A2 publication Critical patent/EP2236159A2/en
Publication of EP2236159A3 publication Critical patent/EP2236159A3/en
Ceased legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Preparation (AREA)

Abstract

According to the present invention a modified release formulation comprising dimebolin HCl and an alginate salt and/or complex salt of alginic acid, together with one or more pharmaceutically acceptable excipients is provided.
EP10158233A 2009-03-31 2010-03-29 Modified release dimebolin compositions Ceased EP2236159A3 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
TR200902500 2009-03-31

Publications (2)

Publication Number Publication Date
EP2236159A2 EP2236159A2 (en) 2010-10-06
EP2236159A3 true EP2236159A3 (en) 2011-12-07

Family

ID=41217706

Family Applications (1)

Application Number Title Priority Date Filing Date
EP10158233A Ceased EP2236159A3 (en) 2009-03-31 2010-03-29 Modified release dimebolin compositions

Country Status (1)

Country Link
EP (1) EP2236159A3 (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2011039686A1 (en) * 2009-09-30 2011-04-07 Pfizer Inc. Latrepirdine oral sustained release dosage forms

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2008069963A1 (en) * 2006-12-01 2008-06-12 Medivation Neurology, Inc. Means for improving cognitive functions and memory based on hydrogenated pyrido (4,3-b) indoles (variants), pharmacological means based thereon and method for the use thereof
WO2008112238A1 (en) * 2007-03-12 2008-09-18 Grey Fox Llc 2, 8-dimethyl-5- [2- (6-methylpyridin-3-yl) -ethyl] -2,3,4, 5-tetrahydro- ih- pyrido [4, 3 -b] indole dihydrochloride (dimebon) for the treatment of chronic pain

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2106864C1 (en) 1995-10-23 1998-03-20 Николай Серафимович Зефиров New approach to treatment of alzheimer's disease
RU2283108C2 (en) 2003-12-08 2006-09-10 Сергей Олегович Бачурин GEROPROTECTING AGENT BASED ON HYDROGENATED PYRIDO[4,3-b]INDOLES (VARIANTS), PHARMACOLOGICAL AGENT BASED ON THEREOF AND METHOD FOR ITS USING

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2008069963A1 (en) * 2006-12-01 2008-06-12 Medivation Neurology, Inc. Means for improving cognitive functions and memory based on hydrogenated pyrido (4,3-b) indoles (variants), pharmacological means based thereon and method for the use thereof
WO2008112238A1 (en) * 2007-03-12 2008-09-18 Grey Fox Llc 2, 8-dimethyl-5- [2- (6-methylpyridin-3-yl) -ethyl] -2,3,4, 5-tetrahydro- ih- pyrido [4, 3 -b] indole dihydrochloride (dimebon) for the treatment of chronic pain

Also Published As

Publication number Publication date
EP2236159A2 (en) 2010-10-06

Similar Documents

Publication Publication Date Title
EP3626253A3 (en) Stable formulations of linaclotide
HK1164050A1 (en) Substituted azoanthracene derivatives, pharmaceutical compositions, and methods of use thereof
WO2011017108A3 (en) Cyclopropyl modulators of p2y12 receptor
WO2011098582A3 (en) Novel crystalline forms of ivabradine hydrochloride
IL218490A (en) Substituted dihydro benzocycloalkyloxymethyl oxazolopyrimidinones, compositions comprising the same and use thereof in the preparation of pharmaceutical compositions
PL2578596T3 (en) Levocarrimycin, pharmaceutical compositions, preparation methods and uses thereof
WO2011017502A3 (en) Linaclotide-containing formulations for oral administration
EP2562172A4 (en) Sphaelactone derivatives, their pharmaceutical compositions, preparation methods and uses
WO2011079193A3 (en) Preparation of bendamustine and its salts
WO2011101863A3 (en) Extended release pharmaceutical compositions of lacosamide
EP2241310A3 (en) Modified release formulations of emoxypine
EP2576576A4 (en) Heterocyclyl-pyridinyl-based biphosphonic acid, pharmaceutically acceptable salt thereof, composition thereof and method of use thereof
WO2011069076A3 (en) Sustained release donepezil formulations
HK1165802A1 (en) Derivatives of benzothiazines, preparation thereof and application thereof as drugs
MY162392A (en) Enteric tablet
WO2009094457A3 (en) Substituted benzhydrylethers
WO2010065586A3 (en) Preparation of capecitabine
MX2012001691A (en) Orally disintegrating compositions of linaclotide.
IL213177A0 (en) Crystal forms, methods of preparation, pharmaceutical compositions and uses of nicousamide
WO2011142731A3 (en) Formulations comprising a third generation cephalosporin and clavulanic acid
EP2498818B8 (en) Microcrystalline cellulose and calcium phosphate compositions useful as pharmaceutical excipients
IL219374A0 (en) Microcrystalline cellulose and calcium phosphate compositions useful as pharmaceutical excipients
MX344189B (en) Formulations of mazindol.
WO2012064304A3 (en) Combinations comprising montelukast
WO2010148314A3 (en) Preparation of esomeprazole and its pharmaceutically acceptable salts

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

AK Designated contracting states

Kind code of ref document: A2

Designated state(s): AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO SE SI SK SM TR

AX Request for extension of the european patent

Extension state: AL BA ME RS

PUAL Search report despatched

Free format text: ORIGINAL CODE: 0009013

AK Designated contracting states

Kind code of ref document: A3

Designated state(s): AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO SE SI SK SM TR

AX Request for extension of the european patent

Extension state: AL BA ME RS

RIC1 Information provided on ipc code assigned before grant

Ipc: A61K 31/437 20060101ALI20111103BHEP

Ipc: A61K 9/20 20060101ALI20111103BHEP

Ipc: A61K 47/30 20060101AFI20111103BHEP

RAP1 Party data changed (applicant data changed or rights of an application transferred)

Owner name: SANOVEL ILAC SANAYI VE TICARET ANONIM SIRKETI

17P Request for examination filed

Effective date: 20120605

17Q First examination report despatched

Effective date: 20121008

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION HAS BEEN REFUSED

18R Application refused

Effective date: 20150203